跳至主要内容
临床试验/ISRCTN56720616
ISRCTN56720616已完成不适用

Glucose-insulin-potassium infusion in patients treated with primary percutaneous coronary intervention for acute myocardial infarctio

etherlands Heart Foundation (Netherlands)0 个研究点目标入组 940 人开始时间: 2005年5月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
940

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • All consecutive patients with symptoms consistent with acute MI of >30 min duration, presenting within 24 hours after the onset of symptoms and with an ST-segment elevation of more than 1 mm (0.1 mV) in two or more contiguous leads on the electrocardiogram, or new onset left bundle branch block, were evaluated for inclusion in this single-center study. Patients presented at our center and patients referred for treatment of high-risk myocardial infarction (MI) from nine referring hospitals without angioplasty facilities were included.

排除标准

  • Patients were excluded when pre-treated with thrombolysis or when an illness associated with a marked restricted life expectancy was present.

研究者

发起方
etherlands Heart Foundation (Netherlands)

相似试验